Group One Trading, L.P. Catalyst Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 8,108 shares of CPRX stock, worth $167,024. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,108

Previous 15,667 48.25%

Holding current value

$167,024

Previous $242,000 33.47%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.19 - $21.35 $114,821 - $161,384	-7,559 Reduced 48.25%	8,108 $161,000
Q2 2024 Aug 14, 2024	BUY	$14.68 - $16.92 $68,364 - $78,796	4,657 Added 42.3%	15,667 $242,000
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $145,111 - $188,381	11,010 New	11,010 $175,000
Q2 2022 Aug 11, 2022	SELL	$6.23 - $8.57 $57,577 - $79,203	-9,242 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.31 - $8.31 $19,588 - $30,655	3,689 Added 66.43%	9,242 $77,000
Q4 2021 Feb 11, 2022	SELL	$5.21 - $7.45 $112,030 - $160,197	-21,503 Reduced 79.48%	5,553 $38,000
Q3 2021 Nov 12, 2021	SELL	$4.85 - $6.04 $379,231 - $472,279	-78,192 Reduced 74.29%	27,056 $143,000
Q2 2021 Aug 10, 2021	BUY	$4.29 - $6.05 $451,513 - $636,750	105,248 New	105,248 $605,000
Q2 2020 Aug 13, 2020	SELL	$3.48 - $5.05 $701,909 - $1.02 Million	-201,698 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.61 - $5.21 $98,644 - $196,911	37,795 Added 23.06%	201,698 $777,000
Q4 2019 Feb 10, 2020	SELL	$3.67 - $5.7 $84,024 - $130,501	-22,895 Reduced 12.26%	163,903 $615,000
Q3 2019 Nov 12, 2019	BUY	$3.89 - $7.43 $581,889 - $1.11 Million	149,586 Added 401.98%	186,798 $992,000
Q2 2019 Aug 09, 2019	BUY	$2.7 - $6.11 $100,472 - $227,365	37,212 New	37,212 $143,000
Q1 2019 May 13, 2019	SELL	$2.11 - $5.33 $35,372 - $89,352	-16,764 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$1.92 - $3.62 $4,719 - $8,897	2,458 Added 17.18%	16,764 $32,000
Q3 2018 Nov 08, 2018	BUY	$2.81 - $3.78 $5,850 - $7,869	2,082 Added 17.03%	14,306 $54,000
Q2 2018 Aug 14, 2018	BUY	$2.26 - $3.84 $23,140 - $39,317	10,239 Added 515.82%	12,224 $38,000
Q1 2018 May 11, 2018	BUY	$2.39 - $4.01 $982 - $1,648	411 Added 26.11%	1,985 $5,000
Q4 2017 Feb 09, 2018	SELL	$2.51 - $4.4 $2,457 - $4,307	-979 Reduced 38.35%	1,574 $6,000
Q3 2017 Nov 15, 2017	BUY	$2.4 - $2.94 $6,127 - $7,505	2,553	2,553 $6,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Catalyst Pharmaceuticals, Inc. Transaction History